Alkermes (ALKS) Gross Margin Growth (3y) (2013 - 2026)
Alkermes (ALKS) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | -954.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -954.00 |
| Mar 31, 2026 | 455.00 |
| Dec 31, 2025 | 568.00 |
| Sep 30, 2025 | 156,894.00 |
| Jun 30, 2025 | 181,109.00 |
| Mar 31, 2025 | 375.00 |
| Dec 31, 2024 | 208.00 |
| Sep 30, 2024 | 16.00 |
| Jun 30, 2024 | 209.00 |
| Mar 31, 2024 | -42.00 |
| Dec 31, 2023 | -325.00 |
| Sep 30, 2023 | 13.00 |
| Jun 30, 2023 | 796.00 |
| Mar 31, 2023 | -105.00 |
| Dec 31, 2022 | 91,194.00 |
| Sep 30, 2022 | -156,545.00 |
| Jun 30, 2022 | -180,723.00 |
| Mar 31, 2022 | 53.00 |
| Dec 31, 2021 | 8,517.00 |
| Sep 30, 2021 | -100.00 |